Institut de Recherche en Cancérologie de Montpellier
In research, Institut de Recherche en Cancérologie de Montpellier stands highest in Medicine (#5,275 of 10,443 worldwide) and Health Sciences (#6,929 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 15.8× its share of world research.
- World rank, 2022–2025
- #9,720 of 28,054 · #12,214 all time
- Rank in France
- #340 of 1,422
- Research works
- 805 ▲ 20% vs 2013–17
- Citations
- 18k 22.5 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 45% world 28%
What is Institut de Recherche en Cancérologie de Montpellier known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,275 of 10,443 | 16.6% | 137 | #5802 | |
| Health SciencesDomain | #6,929 of 11,982 | 16.1% | 143 | #7501 |
Each strip is that field’s whole ranked pool, with the notch where Institut de Recherche en Cancérologie de Montpellier sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institut de Recherche en Cancérologie de Montpellier specialise in?
Where its research is concentrated relative to its size: Oncology takes 15.8× the share of its output that it takes of world research.
- OncologySubfield · 36.7 works16×
- Pulmonary and Respiratory MedicineSubfield · 25.0 works7.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Immunology and Microbiology 2.7×
- Physics and Astronomy 1.6×
- Health Professions 0.8×
- Mathematics 0.7×
- Dentistry 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Neuroscience 0.4×
- Chemistry 0.4×
- Nursing 0.4×
- Economics, Econometrics and Finance 0.3×
- Psychology 0.3×
- Decision Sciences 0.2×
- Environmental Science 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Veterinary 0.1×
- Chemical Engineering 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.0×
- Energy 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Institut de Recherche en Cancérologie de Montpellier?
Ranked on the composite score, Marc Ychou, Gilles Romieu and Michel Fabbro lead among researchers whose main affiliation is Institut de Recherche en Cancérologie de Montpellier.
- 1 Marc Ychou France · #3,443 worldwide 1.2k citations · 77 works
- 2 Gilles Romieu France · #22,172 worldwide 593 citations · 52 works
- 3 Michel Fabbro France · #50,420 worldwide 203 citations · 60 works
- 4 Simon Thézenas France · #113,908 worldwide 119 citations · 35 works
- 5 Stéphanie Nougaret France · #132,819 worldwide 92 citations · 28 works
- 6 William Jacot France · #260,883 worldwide 149 citations · 68 works
- 7 Alain R. Thierry France · #423,975 worldwide 80 citations · 33 works
- 8 Olivia Sgarbură France · #436,903 worldwide 43 citations · 19 works
- 9 H Joyeux France · #557,209 worldwide 46 citations · 32 works
- 10 Véronique D’Hondt France · #695,536 worldwide 57 citations · 27 works
Which keywords describe research at Institut de Recherche en Cancérologie de Montpellier?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Clinical Practice Guidelines, Radiotherapy, Targeted Therapy, Survival Analysis, Clinical Trials and Neoadjuvant Therapy.
- Radiopharmaceuticals
- Molecular Classification
- Radiation Therapy
- Genomic Profiling
- Preoperative Chemoradiotherapy
- Immune Checkpoint Blockade
- Genomic Instability
- Image-Guided Radiotherapy
- Tumor Markers
- Gene Expression
- Cancer Treatment
- Metastatic Breast Cancer
- Prognostic Factors
- Breast Cancer
- Dosimetry
- Cancer
- Neoadjuvant Therapy
- Survival Analysis
- Radiotherapy
- Immunotherapy
- Chemotherapy
- Clinical Practice Guidelines
- Targeted Therapy
- Clinical Trials
- Quality of Life
- Biomarkers
- Tumor Microenvironment
- Metastasis
- Cancer Therapy
- Cytoreductive Surgery
- Molecular Subtypes
- PET Imaging
- Genetic Mutations
- Radiotherapy Physics
- Prognostic Markers
- PD-1 and PD-L1
- Ovarian Cancer
- Breast Tumours
- Treatment Response
- Radioimmunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy27▲ 19×21 topics
- Immunotherapy18▲ 12×16 topics
- Clinical Practice Guidelines17▲ 15×11 topics
- Radiotherapy16▲ 21×13 topics
- Targeted Therapy14▲ 32×5 topics
- Survival Analysis14▲ 25×7 topics
- Clinical Trials13▲ 9.5×12 topics
- Neoadjuvant Therapy13▲ 27×5 topics
- Quality of Life13▲ 4.3×22 topics
- Cancer11▲ 4.1×35 topics
- Biomarkers11▲ 7.9×15 topics
- Dosimetry11▲ 77×2 topics
- Tumor Microenvironment11▲ 12×8 topics
- Breast Cancer10▲ 20×10 topics
- Metastasis10▲ 14×12 topics
- Prognostic Factors10▲ 11×14 topics
- Cancer Therapy8▲ 6.5×15 topics
- Metastatic Breast Cancer7▲ 63×2 topics
- Cytoreductive Surgery7▲ 54×2 topics
- Cancer Treatment7▲ 15×7 topics
- Molecular Subtypes7▲ 40×3 topics
- Gene Expression7▲ 5.2×9 topics
- PET Imaging7▲ 19×4 topics
- Tumor Markers6▲ 39×2 topics
- Genetic Mutations6▲ 7.1×14 topics
- Image-Guided Radiotherapy6▲ 72×1 topic
- Radiotherapy Physics6▲ 72×1 topic
- Genomic Instability6▲ 25×3 topics
- Prognostic Markers5▲ 24×3 topics
- Immune Checkpoint Blockade5▲ 23×1 topic
- PD-1 and PD-L15▲ 23×1 topic
- Preoperative Chemoradiotherapy5▲ 32×2 topics
- Ovarian Cancer5▲ 28×3 topics
- Genomic Profiling5▲ 24×2 topics
- Breast Tumours5▲ 51×1 topic
- Radiation Therapy5▲ 18×5 topics
- Treatment Response5▲ 51×1 topic
- Molecular Classification5▲ 16×4 topics
- Radioimmunotherapy5▲ 84×1 topic
- Radiopharmaceuticals5▲ 84×1 topic
Which research topics does Institut de Recherche en Cancérologie de Montpellier publish most on?
By volume in 2022–2025: Advanced Radiotherapy Techniques, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies and Radiopharmaceutical Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Radiotherapy Techniques Radiation 6 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Breast Cancer Treatment Studies Cancer Research 5 works
- 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 5 works
- 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 4 works
- 6 Cancer Treatment and Pharmacology Oncology 4 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 8 Colorectal Cancer Surgical Treatments Oncology 3 works
- 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 3 works
- 10 Intraperitoneal and Appendiceal Malignancies Surgery 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut de Recherche en Cancérologie de Montpellier's research output changed?
Output in 2018–2022 was 20% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Montpellier
- Université de Montpellier
- Université Paul-Valéry Montpellier
- Centre Hospitalier Universitaire de Montpellier
- Laboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier
- Hôpital Lapeyronie
- École Nationale Supérieure de Chimie de Montpellier
- Hôpital Saint Eloi
- Hôpital Arnaud de Villeneuve
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.